These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 14743588)
21. Rebates and other drug-cost issues. Penna P Manag Care Interface; 2003 May; 16(5):39-40. PubMed ID: 12789863 [No Abstract] [Full Text] [Related]
22. Managed competition, integrated delivery systems and antitrust. Greaney TL Cornell Law Rev; 1994 Sep; 79(6):1507-45. PubMed ID: 10141442 [No Abstract] [Full Text] [Related]
23. Too big? Caremark, AdvancePCS getting close look from feds. Becker C Mod Healthc; 2004 Jan; 34(2):14, 16. PubMed ID: 14959629 [No Abstract] [Full Text] [Related]
24. Competitors share contracts. Lovern E Mod Healthc; 2001 Jan; 31(3):4-5, 10. PubMed ID: 11418946 [No Abstract] [Full Text] [Related]
25. A multidimensional framework for specialty drug management. Bell GK; Baumann SA Manag Care; 2013 Mar; 22(3):30-5. PubMed ID: 23610804 [No Abstract] [Full Text] [Related]
26. The potential for self-interested behavior by pharmaceutical manufacturers through vertical integration with pharmacy benefit managers: the need for a new regulatory approach. Mitchell EL Food Drug Law J; 1999; 54(1):151-83. PubMed ID: 11758556 [No Abstract] [Full Text] [Related]
27. Precipitating factors for pharmaceutical firms. McCarthy R State Health Care Am; 1997; ():39-43. PubMed ID: 10168083 [No Abstract] [Full Text] [Related]
28. Pharmaceuticals issue brief: pharmaceutical assistance programs: year end report--2004. Seay M Issue Brief Health Policy Track Serv; 2004 Dec; ():1-26. PubMed ID: 15724309 [No Abstract] [Full Text] [Related]
29. It's a done deal, but ... Express Scripts, Medco merger still drawing ire. Lee J Mod Healthc; 2012 Apr; 42(15):17. PubMed ID: 22741281 [No Abstract] [Full Text] [Related]
30. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003. MacEachern L Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259 [TBL] [Abstract][Full Text] [Related]
31. New sheriff in town. Health insurers take antitrust enforcement matters into own hands with litany of lawsuits. Taylor M Mod Healthc; 2001 Dec; 31(49):26-8. PubMed ID: 11765364 [No Abstract] [Full Text] [Related]
32. Medco becomes standalone firm. Thompson CA Am J Health Syst Pharm; 2003 Oct; 60(19):1940-1. PubMed ID: 14531236 [No Abstract] [Full Text] [Related]
34. Physician negotiations with managed care plans: a primer of antitrust pitfalls. Ronai SE; Hudner HK Conn Med; 1992 Oct; 56(10):571-6. PubMed ID: 1458883 [No Abstract] [Full Text] [Related]
35. Discriminatory pricing lawsuits could change future of community pharmacy. Flanagan ME Am Pharm; 1994 Oct; NS34(10):20-3. PubMed ID: 7992787 [No Abstract] [Full Text] [Related]
36. Disease management and antikickback regulations. Kozma CM Manag Care Interface; 2003 Dec; 16(12):34-5. PubMed ID: 14750462 [No Abstract] [Full Text] [Related]
37. Bundling patented drugs and medical services: an antitrust analysis. Hurwitz MA Spec Law Dig Health Care Law; 1992 Jan; (155):7-39. PubMed ID: 10115664 [No Abstract] [Full Text] [Related]
38. Don't mail it in. Express Scripts-Medco deal would doom community pharmacists. Clayton E; Archer D Mod Healthc; 2011 Nov; 41(48):25. PubMed ID: 22250363 [No Abstract] [Full Text] [Related]
39. Merck-Medco merger boosts druggists' anger about pricing levels. Scott L Mod Healthc; 1993 Nov; 23(48):16. PubMed ID: 10130120 [No Abstract] [Full Text] [Related]
40. Antitrust enforcement encourages health care providers to cooperate procompetitively. Marx D; Murphy CM Ann Health Law; 1994; 3():1-27. PubMed ID: 10139972 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]